Publicaciones en las que colabora con José Luis Díaz Pérez (9)

2011

  1. A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene

    PLoS ONE, Vol. 6, Núm. 4

2009

  1. Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma

    British Journal of Dermatology, Vol. 160, Núm. 3, pp. 519-526

2008

  1. Complex signatures of selection for the melanogenic loci TYR, TYRP1 and DCT in humans

    BMC Evolutionary Biology, Vol. 8, Núm. 1

  2. Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors

    Carcinogenesis, Vol. 29, Núm. 3, pp. 500-509

2006

  1. H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells

    Carcinogenesis, Vol. 27, Núm. 9, pp. 1787-1796

2000

  1. Interleukin-2 enhances the growth of human melanoma cells derived from primary but not from metastatic tumours

    European Cytokine Network, Vol. 11, Núm. 4, pp. 654-661

  2. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma

    British Journal of Cancer, Vol. 83, Núm. 7, pp. 847-852

1997

  1. Serum-soluble IL-2 Receptor and IL-6 levels in patients with melanoma

    Oncology (Switzerland), Vol. 54, Núm. 5, pp. 400-406

1996

  1. Serum interleukin-6 levels in patients with melanoma.

    The International journal of developmental biology, Vol. Suppl 1